CHICAGO — The American Medical Association (AMA) today announced that the Current Procedural Terminology (CPT) code set has been updated by the CPT Editorial Panel to include a new code for booster doses of COVID-19 vaccine created by Janssen Pharmaceutical Companies of Johnson & Johnson.
The new CPT code for the booster dose of the Janssen COVID-19 vaccine joins unique CPT codes previously issued to COVID-19 vaccine booster doses from Moderna and Pfizer. The CPT codes for reporting COVID-19 vaccine boosters from Janssen and Moderna are effective for use as of Oct. 20. The CPT codes for the Pfizer boosters were made effective on Sept. 22. As with all the CPT codes related to COVID-19 vaccines, the effective dates coincide with the emergency use authorization issued by U.S. Food and Drug Administration (FDA).
“We believe the FDA’s authorization and the CDC's recommendations in support of booster doses, including the option to mix-and-match boosters with authorized vaccines, will help provide continued protection against COVID-19 for those who need it most,” said AMA President Gerald E. Harmon, M.D.
The mix and match option authorized COVID-19 vaccines and boosters provides needed flexibility for efficient and effective vaccination programs. The CPT code set is prepared to support this strategy with product-specific CPT codes that clinically distinguished each coronavirus vaccine and booster to facilitate tracking, reporting and analysis that is needed for data-driven...
Taking your tablets and checking your sugar is only part of living with diabetes. Every day you also decide what to eat, what to trust, and whether the medicine is even necessary. Increasingly, th...